healthWednesday, June 24, 2026

AI in Medicare, chronic care, and Alzheimer's

Today's health news is dominated by the messy reality of AI in medicine: a Medicare pilot program is causing patient harm, while a startup raised $100M to automate chronic care. A case report on psilocybin for Alzheimer's offers a glimmer of hope, and a verdict against a brain supplement reminds us that not all 'science' is sound.

Sources

AI's mixed record

Two stories today capture the double-edged nature of AI in healthcare: one about a government program that's harming patients, the other about a startup that's scaling care.

#01www.seattletimes.comJun 24

Medicare AI use is ‘making patients’ lives more miserable’

A Medicare pilot using AI to review patient care is causing widespread denials and delays, prompting lawmakers to introduce legislation to roll it back. The piece highlights how well-intentioned AI can backfire when transparency and oversight are lacking.

6 min readRead original

#02medcitynews.comJun 24

Cadence Rakes In $100M to Automate Chronic Care at Scale

Cadence's $100M raise underscores the growing appetite for AI-powered chronic care management. The startup's platform adjusts medications in real time for conditions like heart failure and diabetes, aiming to address a massive gap in U.S. healthcare.

3 min readRead original

Promising treatments

A case report on psilocybin for Alzheimer's and a verdict against a memory supplement both touch on brain health, but from very different angles.

#03www.newscientist.comJun 24

Woman with Alzheimer's starts conversing again after taking psilocybin

A woman with severe Alzheimer's began conversing and regained bladder control after a large dose of psilocybin. While just a case report, it adds to the evidence that psychedelics might alter cognition in profound ways.

#04truthinadvertising.orgJun 24

Jury Hands Down Verdict in Prevagen Deceptive Marketing Case -

A federal jury ruled against Prevagen's maker for deceptive marketing of its memory supplement, ordering removal of all challenged claims. It's a reminder that the supplement industry's promises often outpace the evidence.

Also today10

Nederlandse doorbraak in ontwikkeling van biologische pacemaker: ’Zo kunnen we die al tijdens zwangerschap inbrengen’www.telegraaf.nl
Nederlandse onderzoekers van biotechbedrijf PacingCure, onder leiding van cardioloog dr. Geert Boink, hebben een doorbraak bereikt in de ontwikkeling van een biologische pacemaker op basis van gentherapie. Deze biologische pacemaker heeft geen hardware nodig, maakt operaties voor
Utah marks a year of battling measles, with no clear end in sightwww.newsday.com
Utah has been battling measles outbreaks for a full year since June 2025, with over 680 cases reported across nearly every county. Unlike other state outbreaks that were more contained, Utah's spread has been widespread, affecting undervaccinated communities and appearing in heal
Optimising exercise time-of-day for cardiometabolic health: Insights from a systematic review and meta-analysis in varied adult cohorts - PubMedpubmed.ncbi.nlm.nih.gov
This systematic review and meta-analysis investigates whether the time-of-day influences physiological responses to exercise. The researchers searched PubMed, CENTRAL, and Web of Science through June 2023, including clinical trials with human participants classified as healthy, o
Temperatures hit record levels in western Europewww.bbc.co.uk
A severe heatwave in western Europe, particularly affecting France, Spain, and Italy, has led to record temperatures in several major cities. French officials report 40 drowning deaths linked to the heatwave since June 18. Heat alerts are in place, with temperatures in Nice peaki